Alcon stock draws Pershing Square support before November 10 results

Pershing Square has renewed investor focus on Alcon ahead of the eye-care company's third-quarter results. In its Q3 2026 investor letter, the investment firm highlighted strong second-quarter execution, margin expansion and earnings upside against modest expectations, according to Yahoo Finance.

Why Pershing Square likes Alcon

Pershing Square said Alcon raised its full-year outlook to target constant-currency earnings-per-share growth of 12% to 15%. The fund also described foreign exchange as an additional earnings tailwind after what it characterized as robust margin expansion in the second quarter.

The investment firm sees Alcon as a predictable, high-quality compounder rather than simply a recovery trade. It expects mid-teens annual earnings-per-share growth over the next three to five years and says smaller eye-drug development programs could provide additional upside beyond its base assumptions.

Valuation remains central

Pershing Square's thesis is also built on valuation. The fund said Alcon trades at 17 times earnings, compared with a high-20s multiple in earlier years, as sector-wide pressure on European medical-technology shares has weighed on the rating. Pershing Square argues that the company's business progress has not been fully reflected in its market valuation.

That view remains an investor assessment, not a new Alcon forecast. The upcoming report will give shareholders a fresh reference point for sales momentum, profitability and management's view of demand in surgical and vision care.

Alcon stock before the results

Alcon stock traded at 67.07 euros on Lang & Schwarz at 10:41 CET on Friday, November 6, 2026. The quote is a current market indication; the report does not attach a daily direction because the relevant dated Xetra closing comparison is not established here.

Investors can follow the real-time quote of Alcon stock as the market approaches the results.

Swiss equities remain the relevant market context for Alcon, with the SMI providing the main domestic benchmark.

Alcon is scheduled to release its third-quarter results on Tuesday, November 10. The figures and management commentary will show whether the margin gains cited by Pershing Square are translating into sustained earnings momentum.

For more news and analyses on Alcon stock, investors can track the company's next announcements and earnings updates.